Arsanis
ID: 5290895A company developing targeted monoclonal antibody immunotherapies for the treatment of infectious diseases
3
Funding Rounds
$75.5m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Er*** An****** |
|
- |
Funding
Funding series
Funding Series Analysis
The company Arsanis has raised a total of $30m in funding over 3 rounds.
Key Insights:
- Arsanis Series B round: $20m
- Arsanis Series A round: $10m
- Arsanis funding round, April 2017: $45.5m